GlassScriptPhysician profile
Natalie Tyre
NPI 1073776837
$850.65
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $568 · 2022: $283.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $176.94 | 2021-2022 | |
| Amgen INC. | $123.15 | 2021 | |
| Novo Nordisk INC | $74.37 | 2021 | |
| Esperion Therapeutics, INC. | $61.79 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $61.69 | 2021-2022 | |
| Pfizer INC. | $57.90 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.57 | 2021-2022 | |
| Amarin Pharma, INC. | $53.89 | 2021-2022 | |
| Corcept Therapeutics | $32.49 | 2021-2022 | |
| Abbott Laboratories | $23.59 | 2022 | |
| Bausch Health US, LLC | $20.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.72 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.00 | 2022 | |
| Eisai INC. | $17.86 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.72 | 2021 | |
| Astellas Pharma US INC | $16.37 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Tyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.